The mortality rates of bladder malignant neoplasms show notable variation across countries. As of 2024, Eastern European countries like Poland (10.2) and Croatia (9.7) exhibit higher rates, while countries such as Colombia (2.4) and Costa Rica (3.3) show lower rates. Over the past years, trends are stable to slightly increasing in Eastern Europe and some other regions, with variances ranging up to 2.33% as seen in Latvia. However, some countries like Slovenia and Portugal experienced notable declines, demonstrating variability in healthcare outcomes and preventive measures across regions.
For future trends, watch for advancements in precision medicine and early detection technologies, which may contribute to declining mortality rates. Inequalities in healthcare access and the impact of healthcare policy changes will also be critical factors influencing these trends globally.
Top countries in Bladder Malignant Neoplasms Mortality by Country
| # | 10 Countries | Units (Deaths) Per Hundred Thousand Persons, Standardised Rates | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Poland | 10.2 | 2023 | +0.99% | +0.8% | View data |
| 2 | 2 Croatia | 9.7 | 2023 | +1.04% | +0.31% | View data |
| 3 | 3 Latvia | 9.2 | 2023 | +1.1% | +2.33% | View data |
| 4 | 4 Hungary | 9.2 | 2023 | 0% | +0.44% | View data |
| 5 | 5 Greece | 8.6 | 2023 | 0% | +0.47% | View data |
| 6 | 6 Slovakia | 8.6 | 2023 | 0% | +1.46% | View data |
| 7 | 7 Slovenia | 8.5 | 2023 | 0% | -2.2% | View data |
| 8 | 8 Romania | 7.8 | 2023 | 0% | +1.06% | View data |
| 9 | 9 Bulgaria | 7.3 | 2023 | 0% | +1.43% | View data |
| 10 | 10 Czech Republic | 7.2 | 2023 | -1.37% | 0% | View data |
